Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
about
Current perspectives in HIV post-exposure prophylaxis.Beyond the black box: drug- and device-associated hypersensitivity eventsTwo drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.The clinical implications of antiretroviral pharmacogenomics.Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project.Drug hypersensitivity reactions in patients with HIV disease.Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers.Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns.A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.British HIV Association (BHIVA)/British Association for Sexual Health and HIV (BASHH) guidelines on provision of adherence support to individuals receiving antiretroviral therapy (2003).
P2860
Q34434815-FDD4222B-22F7-42EB-B741-9E95D98EF00DQ35026476-86364D83-D0B3-46DD-974A-6CCDE3649AC1Q35861315-C3696900-6263-4B2F-B4CF-8C63DE3D7297Q36497078-4E37E220-8C9D-4D58-9484-875BE33FCC49Q37399082-CDCDECF3-1B33-49E0-A34E-E52A5DE1C536Q40218681-33A3861D-958C-48C8-856E-C2D494FDC380Q42618217-172CD33A-71DD-455A-9E4D-B55E94C8C1A8Q43529025-AB9EFF06-01A3-40B7-8595-9269BE725C80Q44200937-A47B2268-176A-4E24-A074-50167A7D1D02Q50145443-C541CA9A-FD39-4DAD-B859-CA5AD8A6303A
P2860
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@en
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@nl
type
label
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@en
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@nl
prefLabel
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@en
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@nl
P2093
P1433
P1476
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1.
@en
P2093
P304
P356
10.1016/S0140-6736(00)04139-8
P407
P577
2001-03-01T00:00:00Z